PN03A – “Urine Pain Panel Scrn Only”

Update to specimen information and methodology.

Specimen Information:

• Qualitative detection of drug present in the urine. 
• This test is for clinical use only and not intended for employment related testing. 
• Positive screen results are considered presumptive results and are not confirmed. 
• Quantitative confirmation testing is available upon client request. Confirmation testing will be done at an additional charge. 
• This panel is designed to detect pain drugs including buprenorphine, fentanyl, meperidine, oxycodone and tramadol. 
• False negative results may occur if drugs are present below the tests limit of detection.

Methodology: Enzyme Immunoassay